[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Sandra D. van der Vaart net worth and biography

Sandra van der Vaart Biography and Net Worth

EVP of Laboratory Co. of America

Sandy van der Vaart has served as Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary since February 2020.

Prior to her current role, Sandy served as Senior Vice President, Global General Counsel, Chief Compliance Officer and Corporate Secretary. Prior to that, she served as Labcorp’s Senior Vice President, Deputy Chief Legal Officer from September 2015 until February 2019 and Senior Vice President, General Counsel and Assistant Secretary from January 2009 to September 2015. She has been with Labcorp since 2001 and has served in various other roles within the legal department. Prior to joining Labcorp, Sandy was a member of the Health Care Practice Group with Smith, Helms, Mulliss & Moore, and also previously worked for the North Carolina Medical Society as Director of the Society’s Managed Care Department. She is a member of the Association of Corporate Counsel and previously served as Chair of the Health Law Section Council of the North Carolina Bar Association and as President of the North Carolina Society of Healthcare Attorneys. Sandy obtained her B.S. in nursing from the University of North Carolina at Chapel Hill and her J.D. from the University of Virginia School of Law.

What is Sandra D. van der Vaart's net worth?: The estimated net worth of Sandra D. van der Vaart is at least $879,588.90 as of August 19th, 2024. Ms. van der Vaart owns 3,670 shares of Laboratory Co. of America stock worth more than $879,589 as of November 22nd. This net worth approximation does not reflect any other investments that Ms. van der Vaart may own. Learn More about Sandra D. van der Vaart's net worth.
How old is Sandra D. van der Vaart?: Ms. van der Vaart is currently 64 years old. There are 8 older executives and no younger executives at Laboratory Co. of America. Learn More on Sandra D. van der Vaart's age.
How do I contact Sandra D. van der Vaart?: The corporate mailing address for Ms. van der Vaart and other Laboratory Co. of America executives is 358 South Main Street, BURLINGTON NC, 27215. Laboratory Co. of America can also be reached via phone at (336) 229-1127 and via email at [email protected]. Learn More on Sandra D. van der Vaart's contact information.
Has Sandra D. van der Vaart been buying or selling shares of Laboratory Co. of America?: Sandra D. van der Vaart has not been actively trading shares of Laboratory Co. of America in the last ninety days. Most recently, Der Vaart Sandra D. Van sold 2,000 shares of the business's stock in a transaction on Monday, August 19th. The shares were sold at an average price of $227.05, for a transaction totalling $454,100.00. Following the completion of the sale, the executive vice president now directly owns 3,670 shares of the company's stock, valued at $833,273.50. Learn More on Sandra D. van der Vaart's trading history.
Who are Laboratory Co. of America's active insiders?: Laboratory Co. of America's insider roster includes Kerrii Anderson (Director), Jean-Luc Belingard (Director), Lance Berberian (EVP), Brian Caveney (EVP), Jonathan DiVincenzo (EVP and President, Central Laboratories and International), Glenn Eisenberg (CFO), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Peter Neupert (Director), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Laboratory Co. of America's active insiders.
Are insiders buying or selling shares of Laboratory Co. of America?: During the last year, insiders at the medical research company sold shares 19 times. They sold a total of 96,112 shares worth more than $21,235,279.87. The most recent insider tranaction occured on November, 11th when CEO Adam H Schechter sold 6,189 shares worth more than $1,506,835.83. Insiders at Laboratory Co. of America own 0.9% of the company. Learn More about insider trades at Laboratory Co. of America.
Information on this page was last updated on 11/11/2024.

Sandra D. van der Vaart Insider Trading History at Laboratory Co. of America

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/19/2024	Sell	2,000	$227.05	$454,100.00	3,670
5/14/2024	Sell	2,000	$210.83	$421,660.00	5,637
3/28/2024	Sell	3,553	$216.74	$770,077.22	7,637
2/13/2024	Sell	237	$226.45	$53,668.65	7,637
2/8/2024	Sell	259	$222.06	$57,513.54	7,637
6/29/2023	Sell	212	$240.00	$50,880.00	7,605
2/7/2023	Sell	219	$243.01	$53,219.19	5,341
2/3/2023	Sell	173	$253.90	$43,924.70	5,341
9/15/2021	Sell	4,500	$296.78	$1,335,510.00
6/7/2021	Sell	4,500	$266.56	$1,199,520.00	9,737
7/2/2020	Sell	435	$170.00	$73,950.00	4,044
6/24/2020	Sell	872	$160.33	$139,807.76	4,915
2/13/2020	Sell	208	$188.49	$39,205.92	2,819
2/10/2020	Sell	133	$181.99	$24,204.67
7/8/2019	Sell	2,328	$176.75	$411,474.00	2,328

Sandra D. van der Vaart Buying and Selling Activity at Laboratory Co. of America

Laboratory Co. of America Company Overview

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.

Today's Range

Now: $239.67

$238.82

$240.97

50 Day Range

MA: $226.12

$212.04

$246.22

2 Week Range

Now: $239.67

$191.97

$247.99

Volume

436,082 shs

Average Volume

670,227 shs

Market Capitalization

$20.05 billion

P/E Ratio

46.36

Dividend Yield

1.21%

Beta

1.05

Election warning coming true…

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.

Sandra van der Vaart Biography and Net Worth

What is Sandra D. van der Vaart's net worth?

How old is Sandra D. van der Vaart?

How do I contact Sandra D. van der Vaart?

Has Sandra D. van der Vaart been buying or selling shares of Laboratory Co. of America?

Who are Laboratory Co. of America's active insiders?

Are insiders buying or selling shares of Laboratory Co. of America?